Evidence map›Paper›PMID 29643334›Full record

ArticleNature communications2018

Performance of the Trioplex real-time RT-PCR assay for detection of Zika, dengue, and chikungunya viruses.

Gilberto A Santiago, Jesús Vázquez, Sean Courtney, Katia Y Matías, Lauren E Andersen, Candimar Colón, Angela E Butler, Rebecca Roulo, John Bowzard, Julie M Villanueva and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically Compatible Illness and Risk for Infection with Both Viruses.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2019
    Guideline
  2. Trial
  3. Review
  4. Article
  5. Evaluation of the NovaplexInternational journal of molecular sciences · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Economic burden of dengue in Puerto Rico, 2010-2023.Infectious diseases of poverty · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Arbovirus Detection inPathogens (Basel, Switzerland) · 2025
    Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gilberto A SantiagoDivision of Vector Borne Diseases, Dengue Branch, Centers for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, San Juan, PR, 00920, USA.
Jesús VázquezDivision of Vector Borne Diseases, Dengue Branch, Centers for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, San Juan, PR, 00920, USA.
Sean CourtneyDivision of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, 30333, USA.
Katia Y MatíasDivision of Vector Borne Diseases, Dengue Branch, Centers for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, San Juan, PR, 00920, USA.
Lauren E AndersenDivision of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, 30333, USA.
Candimar ColónDivision of Vector Borne Diseases, Dengue Branch, Centers for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, San Juan, PR, 00920, USA.
Angela E ButlerDivision of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, 30333, USA.
Rebecca RouloDivision of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, 30333, USA.
John BowzardDivision of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, 30333, USA.
Julie M VillanuevaDivision of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, 30333, USA.
Jorge L Muñoz-JordanDivision of Vector Borne Diseases, Dengue Branch, Centers for Disease Control and Prevention, National Centers for Emerging and Zoonotic Infectious Diseases, San Juan, PR, 00920, USA. JMunoz@cdc.gov.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence and spread of Zika virus (ZIKV) presented a challenge to the diagnosis of ZIKV infections in areas with transmission of dengue (DENV) and chikungunya (CHIKV) viruses. To facilitate detection of ZIKV infections, and differentiate these infections from DENV and CHIKV, we developed the Trioplex real-time RT-PCR assay (Trioplex assay). Here, we describe the optimization of multiplex and singleplex formats of the assay for a variety of chemistries and instruments to facilitate global standardization and implementation. We evaluated the analytical performance of all Trioplex modalities for detection of these three pathogens in serum and whole blood, and for ZIKV in urine. The limit of detection for the three viruses and in different RNA-extraction modalities is near 10

Indexed as

CalibrationChikungunya FeverChikungunya virusDengueDengue VirusHumansLimit of DetectionMultiplex Polymerase Chain ReactionReagent Kits, DiagnosticReverse Transcriptase Polymerase Chain ReactionZika VirusZika Virus InfectionReagent Kits, Diagnostic

Identifiers

PMID29643334
PMCPMC5895813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.